The response of SAPHO patients to IL-17A blockade may confirm the existence of variable pathophysiological mechanisms in adult SAPHO patients compared to children with CRMO; however, we know nothing about the blocking effect of IL-17 in CRMO. The gene discussed is IL17A; the disease is chronic recurrent multifocal osteomyelitis.